Dallas, Texas - The American Heart Association Institute for Precision Cardiovascular Medicine – dedicated exclusively to advancing precision medicine in cardiovascular care – along with Amazon Web Services (AWS) today announced the winners of the inaugural cash competition of its data mining and innovative development grants.

Washington, DC - Veterans with cancer who receive treatment from the Department of Veterans Affairs (VA) will now have easier access to clinical trials of novel cancer treatments, thanks to an agreement between VA and the National Cancer Institute (NCI), part of the National Institutes of Health.

West Lafayette, Indiana - A Purdue University-affiliated startup developing a novel treatment for a life-threatening lung condition known as acute respiratory distress syndrome, or ARDS, is taking part in a prestigious startup accelerator program where about $2 million in funding is available.

Salt Lake City, Utah - To encourage patients to live healthier lifestyles, researchers at Intermountain Medical Center Heart Institute have adopted Nobel Prize-winning “nudge theory” for medication adherence in cardiovascular patients. Nudging is based on the idea that people don’t always make rational choices with their own best interest in mind. They are influenced by emotions and personal needs, but these choices may not lead to the best outcomes.

Orlando, Florida - According to recent research, the insulin resistance and pancreatic beta-cell (β-cell) dysfunction associated with type 2 diabetes (T2D) was unresponsive to treatment with metformin alone or metformin combined with insulin glargine in youth with impaired glucose tolerance (IGT), which is an element of prediabetes, or early T2D. Additionally, youth with IGT and T2D, compared to adults, are more insulin resistant, and thus their insulin is less effective in lowering blood glucose levels in their bodies.

Washington, DC - National Institutes of Health researchers have identified a naturally occurring lipid—a waxy, fatty acid—used by a disease-causing bacterium to impair the host immune response and increase the chance of infection. Inadvertently, they also may have found a potent inflammation therapy against bacterial and viral diseases.